Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator

Thrombosis and Haemostasis

Volumn 77, Issue 4, 1997, Pages 718-724

  Barrett Bergshoeff, Marrie ^a   Moorman, Femke ^a   Bos, Rogier ^a   Rijken, Dingeman C ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; MANNOSE RECEPTOR; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR; PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CONTROLLED STUDY; DEGRADATION; FETUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

EID: 0030945362     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656040     Document Type: Article

References (44)

1. Stahl PD. The mannose receptor and other macrophage lectins. Curr Opin Immunoll 1992; 4: 49-52.
2. Magnusson S, Berg T. Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial liver cells. Biochem J 1989; 257; 651-6.
3. Taylor ME, Conary JT, Lennartz MR, Stahl PD, Drickamer K. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem 1990; 265: 12156-62.
4. Taylor ME, Bezouska K, Drickamer K. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J Biol Chem 1992; 267: 1719-26.
5. Taylor ME, Drickamer K. Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. J Biol Chem 1993; 268: 399-404.
6. Rijken DC, Wijngaards G, Zaal-De Jong M, Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta 1979; 580: 140-53.
7. Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-41.
8. Bachmann F. Fibrinolytic agents. Fibrinolysis 1995; 9, Suppl. 1; 9-15.
9. Collen D. Fibrin-selective thrombolytic therapy for acute myocardial infarction. Circulation 1996; 93: 857-65.
10. Spellman MW, Basa LJ, Leonard CK, Chakel JA, O'Connor JV, Wilson S, Van Halbeek H. Carbohydrate structures of human tissue-type plasminogen activator expressed in Chinese hamster ovary cells. J Biol Chem 1989; 264: 14100-11.
11. Otter M, Kuiper J, van Berkel TJC, Rijken DC. Mechanisms of tissue-type plasminogen activator (t-PA) clearance by the liver. Ann NY Acad Sci 1992; 667: 43142.
12. Warshawsky I, Bu G, Schwartz AL. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo. J Clin Invest 1993; 92: 937-44.
13. Smedsrød B, Einarsson M. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver. Thromb Haemost 1990; 63: 60-6.
14. Narita M, Bu G, Herz J, Schwartz AL. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. J Clin Invest 1995; 96: 1164-8.
15. Noorman F, Braat EAM, Rijken DC. Degradation of tissue-type plasminogen activator (t-PA) by human monocyte derived macrophages is mediated by the mannose receptor and by the low density lipoprotein receptor-related protein (LRP). Blood 1995; 86: 3421-7.
16. Hasapes JP, Daugherty A, Saffitz JE, Sobel BE. Determinants of the distribution of radiolabeled congeners of tissue-type plasminogen activator and its modification for improved clot imaging. Cor Art Dis 1992; 3: 641-9.
17. Kuiper J, Otter M, Rijken DC, van Berkel TJC. Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. J Biol Chem 1988; 263: 18220-4.
18. Mori K, Kawasaki T, Yamshina I. Isolation and characterization of endogenous ligands for liver mannan-binding protein. Arch Biochem Biophys 1988; 264: 647-56.
19. Brock J, Schulze HA, Neels P, Fischer A, Bremer H, Walzel H. Detection of mannose-binding proteins on mouse lymphocytes. Eur J Cell Biol 1991; 54: 90-4.
20. Noorman F, Braat EAM, Barrett-Bergshoeff MM, Barbé E, van Leeuwen A, Lindeman J, Rijken DC. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukocyte Biol 1997; 61: 63-72.
21. Otter M, Barrett-Bergshoeff MM, Rijken DC. Binding of tissue-type plasminogen activator by the mannose receptor. J Biol Chem 1991; 266: 13931-5.
22. Otter M, Zockova P, Kuiper J, van Berkel TJC, Barrett-Bergshoeff MM, Rijken DC. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator. Hepatology 1992; 16: 54-9.
23. Lennartz MR, Wileman TE, Stahl PD. Isolation and characterization of a mannose-specific endocytosis receptor from rabbit alveolar macrophages. Biochem J 1987; 245: 705-11.
24. Lennartz MR, Cole FS, Shepherd VL, Wileman TE, Stahl PD. Isolation and characterization of a mannose-specific endocytosis receptor from human placenta. J Biol Chem 1987; 262: 9942-4.
25. Bos R, Siegel K, Otter M, Nieuwenhuizen W. Production and characterization of a set of monoclonal antibodies against tissue-type plasminogen activator (t-PA). Fibrinolysis 1992; 6: 173-82.
26. Westerwoud RJ. Improved fusion methods IV. Technical aspects. J Immunol Meth 1984; 77: 181-96.
27. Browne MJ, Dodd I, Carey JE. Chapman CG, Robinson JH. Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology. Thromb Haemost 1985; 54: 422-4.
28. Kluft C, Van Wezel AL, Van der Velden CAM, Emeis JJ, Verheijen JH, Wijngaards G. Large scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells. In: Advances in biotechnological processes, vol 2. Mizrahi A, Van Wezel AL, eds. Alan R Liss Inc, New York USA 1983: pp 97-110.
29. Bos ES, Van der Doelen AA, Van Rooy N, Schuurs AHWM. 3,3′,5,5′-Tetramethylbenzidine as an Ames test negative chromogen for horse-radish peroxidase in enzyme immunoassay. J Immunoassay 1981; 2: 187-204.
30. Dixon M, Webb EC. Chapter VIII Enzyme inhibitors. In: Enzymes. second ed. Academic press Inc., New York USA 1964: pp 315-59.
31. Haltiwanger H, Hill RL. The ligand specificity and tissue localisation of a rat alveolar macrophage lectin. J Biol Chem 1986; 261: 15696-702.
32. Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993; 178: 509-19.
33. Steinbach F, Thiele B. Phenotypic investigation of mononuclear phagocytes by flow cytometry. J Immunol Meth 1994; 174: 109-22.
34. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995; 375: 151-4.
35. Ishizaki J, Hanasaki K, Higashino K, Kishino J, Kikuchi N, Ohara O, Arita H. Molecular cloning of pancreatic group I phospholipase A2 receptor. J Biol Chem. 1994; 8: 5897-904.
36. Hanasaki K, Arita H. Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. Its cellular and tissue distribution. J Biol Chem 1992; 9: 6414-20.
37. Goldstein J, Braverman M, Salafia C, Buckley P. The phenotype of human placental macrophages and its variation with gestational age. Am J Pathol 1988; 133: 648-59.
38. Jones CJP, Fox H. Ultrastructure of the normal human placenta. Electron Microsc Rev 1991; 4: 129-78.
39. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389-400.
40. Ezekowitz RAB. The mannose receptor and phagocytosis. In: Mononuclear phagocytes: biology of monocytes and macrophages, van Furth R, ed. Kluwer Acedemic publishers group, Dordrecht, The Netherlands 1992: pp 208-13.
41. Ofek I, Goldhar J, Keisari Y. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 1995; 49: 239-76.
42. Biessen EAL, Noorman F, van Teylingen M, Kuiper J, Barrett-Bergshoeff, MM, Rijken DC, Bijsterbosch MK, van Berkel ThJC. Design of cluster mannosides as high affinity ligands for the human mannose receptor. J Biol Chem 1996; 271: 28024-30.
43. Noorman F, Barrett-Bergshoeff MM, Biessen EAL, van de Bilt E, van Berkel, ThJC, Rijken DC. Cluster mannosides are able to inhibit mannose receptor mediated tissue-type plasminogen activator (t-PA) degradation by rat and human cells. Hepatology, submitted.
44. Binder BR. Physiology and pathophysiology of the fibrinolytic system. Fibrinolysis 1995; 9, Suppl. 1: 3-8.